The UK market has recently faced challenges, with the FTSE 100 index faltering due to weak trade data from China, highlighting global economic interdependencies. Amid such fluctuations, investors often seek stocks that can withstand broader market pressures while offering potential for growth. Penny stocks, typically associated with smaller or newer companies, may appear outdated but remain a relevant investment area by presenting opportunities for growth at lower price points when backed by strong financial health and fundamentals.
Top 10 Penny Stocks In The United Kingdom
| Name | Share Price | Market Cap | Rewards & Risks |
| Foresight Group Holdings (LSE:FSG) | £4.91 | £549.71M | ✅ 4 ⚠️ 0 View Analysis > |
| Warpaint London (AIM:W7L) | £2.10 | £169.65M | ✅ 3 ⚠️ 2 View Analysis > |
| Ingenta (AIM:ING) | £0.755 | £11.4M | ✅ 2 ⚠️ 2 View Analysis > |
| Integrated Diagnostics Holdings (LSE:IDHC) | $0.5225 | $303.74M | ✅ 4 ⚠️ 2 View Analysis > |
| RWS Holdings (AIM:RWS) | £0.942 | £348.33M | ✅ 5 ⚠️ 2 View Analysis > |
| LSL Property Services (LSE:LSL) | £2.51 | £257.82M | ✅ 4 ⚠️ 1 View Analysis > |
| Alumasc Group (AIM:ALU) | £3.425 | £123.16M | ✅ 4 ⚠️ 1 View Analysis > |
| Begbies Traynor Group (AIM:BEG) | £1.185 | £188.66M | ✅ 4 ⚠️ 3 View Analysis > |
| Croma Security Solutions Group (AIM:CSSG) | £0.725 | £9.98M | ✅ 3 ⚠️ 4 View Analysis > |
| Braemar (LSE:BMS) | £2.38 | £72.51M | ✅ 3 ⚠️ 3 View Analysis > |
Click here to see the full list of 287 stocks from our UK Penny Stocks screener.
Below we spotlight a couple of our favorites from our exclusive screener.
Concurrent Technologies (AIM:CNC)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Concurrent Technologies Plc, with a market cap of £200.52 million, designs, develops, manufactures, and markets single board computers for system integrators and original equipment manufacturers.
Operations: The company generates revenue of £44.57 million from the design, manufacture, and supply of high-end embedded computer products.
Market Cap: £200.52M
Concurrent Technologies Plc, with a market cap of £200.52 million, has shown robust financial health and strategic growth in the tech sector. The company is debt-free, with short-term assets significantly exceeding liabilities. Recent earnings reports indicate stable revenue growth to £21.06 million for the half-year ended June 2025, alongside securing substantial contracts in both US and UK defense sectors worth millions of dollars. These contracts highlight Concurrent's expanding role in providing high-performance computing solutions. Additionally, product innovations like the Apollo system and Bragi graphics card enhance its portfolio for demanding environments, supporting long-term sustainability and market presence.
- Navigate through the intricacies of Concurrent Technologies with our comprehensive balance sheet health report here.
- Understand Concurrent Technologies' earnings outlook by examining our growth report.
Kitwave Group (AIM:KITW)
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Kitwave Group plc operates in the United Kingdom as a food and drink wholesaler, with a market cap of £193.43 million.
Operations: The company's revenue is derived from three main segments: Ambient (£222.49 million), Foodservice (£298.67 million), and Frozen & Chilled (£246.87 million).
Market Cap: £193.43M
Kitwave Group plc, with a market cap of £193.43 million, operates as a food and drink wholesaler in the UK. The company is trading at 39.7% below its estimated fair value and has high-quality past earnings despite recent negative growth (-10.6%). Kitwave's debt is well covered by operating cash flow (54.5%), though it carries a high net debt to equity ratio (54.1%). Its short-term assets exceed both short- and long-term liabilities, indicating solid liquidity management. Recent fiscal year-end changes aim to better align financial statements with business activities, potentially improving transparency for investors moving forward.
- Jump into the full analysis health report here for a deeper understanding of Kitwave Group.
- Learn about Kitwave Group's future growth trajectory here.
NIOX Group (AIM:NIOX)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: NIOX Group Plc specializes in designing, developing, and commercializing medical devices for asthma diagnosis, monitoring, and management globally, with a market cap of £313.37 million.
Operations: The company generates revenue primarily from its NIOX® segment, which accounted for £46 million.
Market Cap: £313.37M
NIOX Group Plc, with a market cap of £313.37 million, is trading at 36% below its estimated fair value. Despite recent negative earnings growth of -55.5%, the company has demonstrated profitability over the past five years with an annual earnings growth rate of 54.2%. NIOX's net profit margins have decreased to 10.7% from last year's 28.2%, yet it remains debt-free and financially stable, with short-term assets exceeding liabilities significantly (£22.4M vs £6M). Recent half-year results show improved sales (£25.2 million) and net income (£5.9 million), indicating potential recovery in financial performance.
- Click to explore a detailed breakdown of our findings in NIOX Group's financial health report.
- Assess NIOX Group's future earnings estimates with our detailed growth reports.
Make It Happen
- Access the full spectrum of 287 UK Penny Stocks by clicking on this link.
- Searching for a Fresh Perspective? Outshine the giants: these 24 early-stage AI stocks could fund your retirement.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Kitwave Group might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com